Fundraising Fox

Quotient Therapeutics

76 employees on LinkedIn · 1 known investors

Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.

AI & Machine LearningBiotechDeep Tech

Investors · 1

Flagship Pioneering✓ verifiedCambridge · $500K – $10M

Funding

SEC filings, press & company announcements

$50M disclosed across 1 of 2 rounds · 2023–2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Top Biotech VC Firms 2026: Leading Biotech Startup Investors Guidequbit.capital · Apr 2026Quotient Therapeutics Raises $25M to Unlock a New Universe of Genetic Variation for Transformational Medicinesleadsontrees.com · May 2025Flagship launches Quotient Therapeutics, its first UK startupcen.acs.org · Nov 2023Quotient Therapeutics secured US$50,000,000 in a remarkable growth funding round.startupmag.co.uk · Nov 2023Quotient Therapeutics Raises $50M in Initial Fundingfinsmes.com · Nov 2023

Frequently asked questions

What does Quotient Therapeutics do?
Quotient is a biotechnology company applying somatic genetics research to R&D, developing its work through a proprietary platform. It was founded by Flagship Pioneering in collaboration with academic co-founders.
Who are Quotient Therapeutics's investors?
Quotient Therapeutics's investors include Flagship Pioneering.
How much funding has Quotient Therapeutics raised?
Quotient Therapeutics has disclosed $50M raised across 1 of its 2 known rounds.